Reports and Intelligence: Global human insulin market during 2013-2020

Human insulin is used to regulate glucose metabolism in the human body.  It also helps in regulating carbohydrate and fat metabolism in people with diabetes. With the growing incidence of diabetes across the globe, insulin is a much needed glucose regulating method for the patients.

Reports and Intelligence adds a report titled “Global Human Insulin Market (Product Type, Brand and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 – 2020.” The report states that the global human insulin market is expected to witness a significant growth rate during the forecast period.

Get access to detailed report at: http://www.reportsandintelligence.com/human-insulin-market

The report examines the global market through various segments such as types, brands, technologies, geographies and competitive landscape. It also provides deep insights of the global market by analyzing market trends and various factors influencing the growth of the market.

The growing number of obesity cases, changing lifestyle, geriatric population and inadequate healthcare conditions in many regions are leading to the growth of diabetes. The growing number of diabetic patients is fuelling the growth of the global human insulin market. Also, technological advancements such as insulin pens and many more coming up would propel the growth of the global market.

The report segment on the product type mainly includes modern and traditional types of human insulin. Traditional human insulin segment consists of Intermediate Acting, Premixed and Short Acting types of Human Insulin. Modern human insulin types includes Long Acting, Rapid Acting Premixed types of human insulin. The efficiency of the modern human insulin is making it a preferred choice by the end users. Long acting and premixed modern insulin are the main types of human insulin that are expected to grow rapidly during the forecast period.

As per the report, Asia-Pacific and LAMEA are the fastest growing geographical regions with large number of diabetic patients, improving healthcare conditions and favorable government regulations.  Other geographical regions included in the report are North America and Europe, out of which North America would dominate the global human insulin market in terms of revenue.

The report would provide the market investors with comprehensive knowledge of the global market and competitive scenario at the global level. It provides extensive information of the developmental strategies adopted by the global players and technological advancements in the field of human insulin market.

Report profiles the following companies from the global market:                

          Eli Lilly

          GlaxoSmithCline

          Biocon

          Sanofi Aventis

          Julphar

          Novo Nordisk

          SemBioSys

          Wockhardt